Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
Main Authors: | Jocelyne Just, Melisande Bourgoin, Flore Amat, Nathalie Cottel, Nathalie Lambert, Stephanie Wanin |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2020-12-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/6/4/00339-2020.full |
Similar Items
-
Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
by: Koki Fujii, et al.
Published: (2020-11-01) -
Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma
by: FitzGerald JM, et al.
Published: (2019-12-01) -
Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma
by: Ken Ohta, et al.
Published: (2018-04-01) -
The clinical profile of benralizumab in the management of severe eosinophilic asthma
by: Francesco Menzella, et al.
Published: (2016-12-01) -
Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
by: Takanori Numata, et al.
Published: (2020-08-01)